Effectiveness of Second mRNA COVID-19 Booster Vaccine in Immunocompromised Persons and Long-Term Care Facility Residents

Effectiveness of Second mRNA COVID-19 Booster Vaccine in Immunocompromised Persons and Long-Term Care Facility Residents

We used a nationwide population registry in South Korea to estimate the effect of a second booster dose of mRNA COVID-19 vaccine on the risk for laboratory-confirmed SARS-CoV-2 infection, critical infection, and death in immunocompromised persons and long-term care facility (LTCF) residents. During...

Full description

Bibliographic Details
Main Authors: Yoo-Yeon Kim, Young June Choe, Jia Kim, Ryu Kyung Kim, Eun Jung Jang, Seon Kyeong Park, Do-Sang Lim, Seonju Yi, Sangwon Lee, Geun-Yong Kwon, Jee Yeon Shin, Sang-Yoon Choi, Mi Jin Jeong, Young-Joon Park
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2022-11-01
Series:Emerging Infectious Diseases
Subjects:
COVID-19
coronavirus disease
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
viruses
respiratory infections
Online Access:https://wwwnc.cdc.gov/eid/article/28/11/22-0918_article

Internet

https://wwwnc.cdc.gov/eid/article/28/11/22-0918_article

Similar Items